ArticleESMO gastrointestinal oncology2026

Phase II randomised study of magrolimab combined with bevacizumab-FOLFIRI in patients with previously treated advanced inoperable metastatic colorectal cancer.

M Fakih et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.